該当箇所へ
Beyond Software | Genedata Biologics

バイオ創薬の課題解決へ
  

カスタマー

Genedata Biologics®は、世界中の大手バイオファーマやバイオテクノロジー企業で広く使用されており、組織全体からグループ単位まで、様々な規模で導入されています。導入にあたっては、技術移管、カスタマイズ、トレーニング、最新バージョンリリース時の新機能紹介なども実施します。

MorphoSys社:
バイオ研究開発のデジタル化

MorphoSys社は10年前、バイオロジクス研究開発のデータ管理ソリューションを探していました。低分子向けのソリューションが選択肢として挙がりましたが、それではタンパク質のなどバイオ高分子の創薬業務に対応できないとすぐに気づきました。Genedataは、バイオ医薬品向けに設計されたエンタープライズプラットフォームを提供しており、バイオロジクスワークフローやアミノ酸配列情報が低分子の構造情報とは全く異なることを理解しています。MorphoSys社はGenedataに出会い、その後長く続くパートナー関係が生まれました。

Janssen社、Celgene社、Aptevo社:
より良い選択

Genedata Biologicsは、バイオ医薬品の研究開発プロセスを加速させ、創薬ワークフローの全ての情報へ即時アクセスできる一元的なデータベースを提供しています。Janssen社・Celgene社・Aptevo社はこのプラットフォームを使用して、より良い研究判断を下す上で重要なビジネスインテリジェンスを得るために、どのように蓄積したデータから必要な収集、傾向を観察し、機械学習戦略を実行するか協議しています。

Crescendo Biologics社:
Genedataを使う6つの理由

Crescendo Biologics社は、がん免疫と次世代のADC領域において、抗体よりも小さいながらも安定性の高いペプチド医薬を開発しています。製品デザインの複雑性と規模、そして候補試験中に生成される膨大なデータ量により、研究開発活動の全てを支える拡張可能なプラットフォームが必要でした。Genedata Biologicsは、トランスジェニックマウスへの免疫付与、リード選択、分子修飾、最終候補剤分子の評価を含めた創薬プロセス全体をサポートします。全てのデータを一元管理する本プラットフォームは、彼らのオペレーションにとって必要不可欠です。

Biopharma Partner Symposium

Genedataコミュニティー

Genedata Biopharma Partner Symposium
2024年3月6日~7日 | スイス・バーゼル

Genedata Biologics Partner Symposiumは、バイオファーマの研究開発とITが融合したイベントで、様々な導入企業のGenedataプラットフォーム導入・活用方法をご紹介します。発表や懇談は、新規分子フォーマット(多重特異性抗体、TCR、AAVなど)、質量分析(MS)によるMulti-Attribute Method(MAM)アプローチ、次世代シーケンス(NGS)、分子による患者プロファイリングといった革新的なアプリケーションや業界の新要件、そしてバイオ医薬品・療法の研究開発における自動化・標準化の動きに焦点をあてたものになります。業界を牽引するバイオファーマがどのようにGenedataプラットフォームを導入・運用・活用し、バイオ医薬品・療法の研究開発を効率化し、スループットを向上させたか、是非シンポジウムに参加してご確認ください。

詳細

カスタマーストーリー

Pfizer社、Genedata Biopharma E2E ワークフロープラットフォームを導入

After conducting a thorough market evaluation to identify an off-the-shelf enterprise system for large-molecule discovery, Pfizer implemented Genedata Biologics as their central repository for their biologics discovery data, including screening, molecular biology, engineering, expression, purification, and analytics.

MorphoSys社、Genedata Biologicsで抗体の研究開発を加速

After a formal selection process, MorphoSys adopted Genedata Biologics as their enterprise workflow platform because Genedata Biologics is the only off-the-shelf platform uniquely built for biopharmaceutical R&D.

Immatics社、Genedata Biologicsで細胞療法の研究開発をデジタル化

Leveraging Genedata’s out-of-the-box functionality, Immatics is streamlining CGT processes and increasing R&D efficiency. Genedata's scientific consultants also helped to configure Immatics-specific CGT workflows and integrate laboratory instruments so rollout of the platform was straightforward – and fast.

カスタマー講演

世界中の大手バイオファーマやバイオテック企業がGenedata Biologicsを活用して研究開発活動の革新を実現しています。定期的に発表の機会を設けているため、Pfizer、Bayer、UCB、武田薬品、AbbVie、GSK、Kymab、Sanofiやその他の企業がGenedataプラットフォームでどのようにプロセスを円滑化し、バイオ医薬品の開発業務を効率化しているか学ぶことができます。

詳細

カスタマーの声

Icosagen

CRDMO Digitalizes Antibody Discovery

"Since many of the biopharma and biotechs we work with as a CRDMO also use Genedata, it makes it even easier to exchange data with our customers. We are also very pleased with Genedata’s support and global presence, which gives us local access to support our operations both in Europe and the U.S.”

Sanofi

Driving AI-Based Biopharma R&D

"We chose Genedata Biologics to support our quickly growing biopharmaceutical R&D operations and enable scientific innovation, including R&D of novel modalities such as bi- and multi-specifics and other next-gen therapeutics."

Light Chain

Structured R&D Data in SaaS Solution

"We can’t risk storing our business-critical data in systems that may result in unstructured or corrupted data when projects or people change. Genedata Biologics will act as our organizational memory to structure and protect our assets and ensure that data can always be accessed and found."

Charles River

CRO Digitalizes Antibody Discovery Programs

“Genedata Biologics allows us to digitalize our work, increasing quality and efficiency of our antibody discovery and protein production by integrating processes and connecting our global operations. Our partners and clients who also use the platform will see the benefit of easier information sharing.” 

Mink

Driving Innovation in Cell Therapy R&D

“Genedata’s platform was the clear choice to support and integrate our full cell therapy discovery and development efforts. This will further augment the ability for our cell and gene therapy scientists to capture, process, and interpret R&D data.”

Ligand

Supporting Interconnected mAb Workflows

“Genedata Biologics was recommended repeatedly as the industry standard for biopharmaceutical R&D and is the only such software developed specifically for antibodies."

UCB

Central Registration & Data Management Platform

"Genedata seamlessly integrates into an existing research informatics environment and supports the full process through automation, standardization, and integration."

Pfizer

Flexible Architecture for Proprietary Configuration

“One of the reasons we chose Genedata Biologics was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.”

Genmab

Genedata Enables Data-Informed Decisions

“We are excited to implement the Genedata Biopharma Platform as a central integrated data backbone to streamline the capture, integration, democratization, and analysis of increasingly complex and diverse data types across Genmab’s discovery and clinical workflows."

Dragonfly

Genedata Supports Development of Novel Multi-Specific Therapies

“We selected Genedata Biologics because of its unique workflow and registration engine that supports processes from candidate selection all the way through IND filings and commercialization.”

Aptevo

Esablished, Off-the-Shelf Product Deployed Quickly

“We appreciate Genedata Biologics’ flexible business model, which made it possible for a company of our size to adopt a market-leading platform solution.”

Boehringer Ingelheim

Genedata Accelerates Antibody Discovery at BI

"We undertook a thorough selection process to find the best antibody workflow platform and Genedata Biologics was the obvious choice."

Agenus

Genedata Provides Backbone System

“Genedata Biologics was the clear choice as a backbone system to support the full diversity of our complex and rapidly evolving antibody discovery processes in the US and the UK.”

Immatics

TCR Information Centrally Stored in Genedata

“Genedata Biologics gives all our R&D groups a central place to record and access TCR-related information in real time, along the end-to-end workflow."

Kymab

Flexible Business Model Works for SMEs

"Thanks to Genedata’s flexible business model, we are able to take advantage of Genedata’s unique technology under terms that work well for a company of our size."

Orion Pharma

Orion Chooses Open & Scalable System

"Collaborating with CROs is a key part of our strategy, so we require an open and scalable system able to capture and integrate all data generated by our CRO network."

Merck

Mission-Critical Data Centrally Stored in Genedata

“We are rapidly expanding our biotherapeutic R&D activities and needed a scalable, flexible platform that we could quickly and easily implement. We chose Genedata Biologics as it is the only out-of-the-box platform on the market dedicated to large-molecule R&D.”

Crescendo Biologics

ADC Discovery Using Scalable Backbone System

“Thanks to its flexible architecture, Genedata Biologics can truly support our entire discovery process – right through from the immunization of transgenic mice, to lead selection, molecular modification and final candidate assessments. Genedata Biologics is a key component of our growth plans in the immuno-oncology and next-generation ADC space.”

Bayer

First Commerical Data Management Solution

“Our collaboration with Genedata to develop a biologics data platform has been very successful. A commercial data management solution such as this has been sorely lacking in protein therapeutics."

Morphosys

Streamlining Operations & Increasing Throughput

“We made a decision early on to use Genedata Biologics as MorphoSys’ workflow backbone to accelerate our drug discovery efforts and have watched as Genedata Biologics has become the global industry standard for biopharma discovery organizations."

   
 

バイオ医薬品創薬を加速

製品デモをご希望の方